Rick Doblin Debunks Myths and Details Breakthroughs in MDMA Research

Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company.

maps.org

Taken from JRE #1964 w/Rick Doblin: https://open.spotify.com/episode/1EMSI2KxCHhbyEwCBnIfsw?si=b75dc222759f451b&nd=1